Training program for researchers studying rheumatic and musculoskeletal diseases
The Rheumatic and Musculoskeletal Disease Epidemiology and Outcomes Training Program at the University of North Carolina
This program at the University of North Carolina is training new researchers to better understand and find treatments for rheumatic and musculoskeletal diseases, so they can help improve the lives of people affected by these conditions.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11080987 on NIH RePORTER |
What this research studies
This program at the University of North Carolina aims to train independent researchers in the field of rheumatic and musculoskeletal diseases (RMDs). It focuses on understanding the causes, effects, and treatments of these conditions, which affect a significant portion of the population. The training will involve both predoctoral and postdoctoral trainees from diverse backgrounds, equipping them with the skills needed to lead future research in this area. By enhancing the workforce in RMD epidemiology and outcomes research, the program seeks to address the growing need for expertise in this field.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals affected by rheumatic and musculoskeletal diseases or those interested in the epidemiology of these conditions.
Not a fit: Patients who do not have rheumatic or musculoskeletal diseases may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and management of rheumatic and musculoskeletal diseases, ultimately benefiting patients through better treatment options.
How similar studies have performed: Other training programs in similar fields have shown success in enhancing research capabilities and improving patient outcomes, indicating a positive precedent for this approach.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Callahan, Leigh Fleming — Univ of North Carolina Chapel Hill
- Study coordinator: Callahan, Leigh Fleming
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.